Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators 7-amino-1-3-dihydro-2H-imidazo-4-5-b-quinolin-2-ones-and-method-for-inhibiting-phosphodiesterase-and-blood-platelet-aggregation

 Method and composition for preventing NSAID-induced renal failure
We claim: 1. A method of preventing renal failure in a warm-blooded animal resulting from ...


 Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
The purpose of this invention is to produce, by recombinant DNA techniques, HSV glycoproteins or ...


 Biphenyl derivatives
We claim: 1. A diastereoisomer or optically active antipode of a compound of the formula ##STR5## ...


 Fluoralkylatedcarbapenem derivatives
We claims: 1. A compound of the formula ##STR37## wherein R.sub.1 is hydrogen or methyl, and R.sub.2...


 Testosterone derivatives
OF THE INVENTION EXAMPLE 1 Testosterone Methyl Ether ##SPC3## A solution of 50 g. of testosterone ...


 Method of treating arthritic disease
OF THE INVENTION The active compounds of the present invention are obtainable as crystalline ...


 Therapeutic agents containing tamoxifen and salts thereof
What is claimed is: 1. A method for the treatment of psoriasis in a warm-blooded animal requiring ...


 Lactams, their synthesis and use in cosmetic compositions
I claim: 1. A process for the synthesis of a lactam which comprises the steps of treating an ...


 Method of growing hair
We claim: 1. A method for inducing, maintaining or increasing hair growth which comprises topically ...


 Viscoelastic dentifrice composition
We claim: 1. A linear viscoelastic dentifrice composition in the form of a toothpaste or dental gel ...


 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation

Details
Inventors: Meanwell, Nicholas A.; Wright, John J.;
Assignee: Bristol-Myers Company (New York, NY)
Primary Examiner: Jiles; Henry R.
Assistant Examiner: Northington; Zinna
Attorney, Agent or Firm: Uloth; Robert H.

Novel series of 2,3-dihydro-2-oxo-1H-imidazo[4,5-b]quinolinyl amine derivatives of Formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl; R.sub.2 is hydrogen, lower alkyl, lower alkoxy, halogen; R.sub.3 is hydrogen, lower alkyl; R.sub.4 is hydrogen, lower alkyl, alkanoyl, phenylalkanoyl wherein phenyl is optionally substituted with halogen, lower alkyl, lower alkoxy; R.sub.3 and R.sub.4 are joined together to form morpholinyl, piperidinyl or pyrrolidinyl optionally substituted with --CO.sub.2 R.sub.5 or ##STR2## wherein R.sub.5 is hydrogen or lower alkyl, and R.sub.6 is hydrogen, lower alkyl, cycloalkyl; 4-R.sub.7 -piperazinyl wherein R.sub.7 is --CO.sub.2 R.sub.8 wherein R.sub.8 is lower alkyl, phenyl optionally substituted with up to 2 halogen, lower alkyl or lower alkoxy; phenylalkanoyl of 7 to 10 carbon wherein phenyl is unsubstituted or independently substituted with up to 2 halogen, lower alkyl, lower alkoxy. The compounds are cyclic AMP phosphodiesterase inhibitors and are particularly useful as inhibitors of blood platelet aggregation and/or as cardiotonic agents.

DETAILED DESCRIPTION OF THE INVENTION The compounds of the instant invention comprise those of Formula I ##STR15## wherein R.
sub.
1 is hydrogen, lower alkyl; R.
sub.
2 is hydrogen, lower alkyl, lower alkoxy, halogen; R.
sub.
3 is hydrogen, lower alkyl; R.
sub.
4 is hydrogen, lower alkyl, alkanoyl of 1 to 6 carbon atoms, phenylalkanoyl of 7 to 10 carbon atoms wherein phenyl is optionally substituted with halogen, lower alkyl, or lower alkoxy; R.
sub.
3 and R.
sub.
4 are joined together to form morpholinyl, piperidinyl or pyrrolidinyl optionally substituted with --CO.
sub.
2 R.
sub.
5 or ##STR16## wherein R.
sub.
5 is hydrogen or lower alkyl, and R.
sub.
6 is hydrogen, lower alkyl, cycloalkyl of 5 to 7 carbon atoms; 4-R.
sub.
7 -piperazinyl wherein R.
sub.
7 is --CO.
sub.
2 R.
sub.
8 wherein R.
sub.
8 is lower alkyl, phenyl optionally substituted with up to 2 halogen, lower alkyl or lower alkoxy; phenylalkanoyl of 7 to 10 carbon wherein phenyl is unsubstituted or independently substituted with up to 2 halogen, lower alkyl, lower alkoxy; or a pharmaceutically acceptable salt thereof.
It is understood that as used herein limitations of Formula I are defined as follows: The term "halogen" or "halo" comprehends fluorine, iodine, and most preferably bromine and chlorine.
The term "lower alkyl" refers to a branched or unbranched saturated hydrocarbon chain containing from 1 to 4 carbon atoms; specifically, methyl, ethyl, n-propyl, isopropyl, n-butyl, secondary butyl and tert.
-butyl.
The terms "alkyl of 1 to 4 carbon atoms" and "lower alkyl" are used interchangeably and specific terms may be represented by conventional symbols, i.
e.
, Me.
dbd.
CH.
sub.
3, Et.
dbd.
C.
sub.
2 H.
sub.
5, etc.
The term "lower alkoxy" comprehends ethers containing from 1 to 4 carbon atoms as defined for alkyl; such as methoxy, ethoxy, isopropoxy, tert.
-butoxy, and the like.
The term "alkanoyl of 1-6 carbon atoms" comprehends both unbranched or branched aliphatic acids such as, for example, formic acid, acetic acid, propanoic acid, butyric acid, pentanoic acid, hexanoic acid or any isomer of these acids which has up to 6 carbons atoms and is fully saturated



Related patents
  Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
OF THE INVENTION The compounds of the instant invention comprise those of Formula I ##STR13## wherein n is 3 to 5; R.sub.1 is alkyl of 1 to 4 carbon atoms; R.sub.2 is ...
  Nocardia species capable of producing nargenicin C.sub.1
OF THE INVENTION The antibiotic of this invention, nargenicin C.sub.1, is produced by fermentation of a new microorganism designated as culture N467-32, which was ...
  Combination therapy using antitumor immunotoxins with tumor necrosis factor
OF THE INVENTION A. Definitions As used herein, "therapeutic" treatment refers to administration of the combination of the invention to a subject after a tumor burden ...
  Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
What is claimed and desired to be secured by U.S. Letters Patent is: 1. Method for isolating a nontoxic, nonpyrogenic polysaccharide antigen from the crude slime of P...
  Heterocyclic alkylaminoheterocycles
What we claim is: 1. A compound of the formula: ##STR5## wherein A taken together with the nitrogen and carbon atoms shown forms a quinazoline, thiazoline, or quinoline ...
  Antibiotic SF-1130-x.sub.3 3 substance and production and use thereof
OF THE INVENTION According to a first aspect of this invention, therefore, there is provided SF-1130-x.sub.3 substance which is an oligosaccharide of weakly basic ...
  Enzymatic degradation of lipopolysaccharide bioemulsifiers
OF THE INVENTION 6.1. Isolation of Microorganisms That Produce Lipopolysaccharide Bioemulsifier-Degrading Enzymes A wide variety of naturally occurring microorganisms, ...
  Bath preparation comprising fumaric acid and carbonate salt
OF THE INVENTION The carbonate which can be used in the bathing preparation of the present invention is not critical to the present invention. Examples thereof include ...
  Selective hydrogenation products of C-076 compounds and derivatives thereof
What is claimed is: 1. A compound having the formula: ##STR4## wherein R.sub.1 is iso-propyl or sec-butyl; R.sub.2 is methoxy, hydroxy or loweralkanoyloxy; and R.sub.3 ...
  Dental implant
We claim: 1. In a dental implant having an implant portion adapted to be inserted into the bone, the improvement comprising said portion, when viewed from side to side ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved